MarketResearchBlog

 Between 2022 and 2032, the demand for Urgent Care Market is anticipated to increase globally at a moderate CAGR of roughly 5.4%, resulting in sizable revenues by the end of the projection period (2032). The rising prevalence of chronic diseases and accidents that necessitate emergency medical attention, together with rising healthcare institution investments in establishing and expanding urgent care infrastructure, are driving market growth. Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Urgent Care Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast. The team of analysts at Future Market Insights are focussing on research and market study to produce different Urgent Care Market forecasts and predictions at both national and international levels. They have considered several lea

 The Medical Bed Market  is expected to expand from US$3.4 billion in 2022 to US$5.5 billion in 2032 as a result of rising investments in medical infrastructure. From 2022 to 2032, the medical bed market is projected to grow at a 4.9% CAGR. In February 2022, the Government of New Delhi announced the establishment of 7 new hospitals, which would lead to the induction of nearly 7,000 new medical beds. In another instance, in 2020, China built an emergency hospital with 1,000 beds, 30 ICUs, and various isolation wards in only 10 days. Integration of smart technologies in medical beds is anticipated to offer significant opportunities to the market in the assessment period. As per a commercial software maintained by the Environmental Systems Research Institute, ArcGIS, there were about 816,554 staffed bed demands with smart features across the hospitals in the U.S till September 2020. Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-15013 Furthermore, risi

 The  Oxygen Therapy Equipment Market  is anticipated to reflect a CAGR of 7.4% during the period of 2022-2032. The Oxygen Therapy Equipment Market is anticipated to reach US$ 6.4 Billion in 2032, from US$ 3.1 Billion in 2022. This study explains that the Chronic respiratory diseases affect more than 1 billion people, globally, as per the Global Asthma report, 2018. COPD, with tobacco smoking as its root cause, has affected a significant part of the world population, as per the World Health Organization. These factors are expected to accelerate the growth of the Oxygen Therapy Equipment Market during the forecast period. The advent of the technologically advanced oxygen source and delivery devices, which offers efficient patient care, is expected to boost the industry. These advancements include flow regulating devices, sensors, and conjunction of delivery devices with pulse dose meters. The adoption of O 2  therapy is increasing owing to the potential benefits such as controlled flow,

 In 2022, the global Preclinical Medical Device Testing Services Market had a market value of US$ 2.8 billion, and by 2032, it is anticipated to reach a market value of US$ 6.63 billion, growing at a CAGR of 9%. Increased product complexity and stringent governmental restrictions are two factors contributing to the growth of the preclinical medical device testing services market. In the historical period from 2017 to 2021, the market for preclinical medical device testing services experienced a CAGR of 5.5%. Integration of artificial intelligence along with Internet of Things is playing a key role in advancing preclinical medical device testing services. In addition, the growing burden of treating diseases at an early stage is creating opportunities for the development of preclinical medical device testing services. Manufacturers too are researching and analyzing preclinical devices to solve problems related to the same at an early stage. This, in turn, is driving the demand for precl

 The market for  Laparotomy Sponges Market  is anticipated to document a steady CAGR of 6.6% across the forecast period ranging from 2022 to 2032. At the conclusion of the said period of assessment, a valuation worth US$ 2.1 Billion is projected for the market. In addition, a Y-o-Y expansion worth 9.1% is expected, rising from US$ 1.1 Billion to US$ 1.2 Billion from 2021-2022. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Laparotomy Sponge market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Laparotomy Sponge market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Get a Sample Copy of the Report

 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, enc

 The global  Cosmetic Implants Market  is estimated to garner US$ 17.9 Billion while exhibiting a 5.8% CAGR during the forecast period. The growing support from several governments is likely to fuel the market growth in the coming years. The industry is expected to secure US$ 10.2 Billion in 2022. Increasing expenditure on healthcare, growing awareness about cosmetic procedures, and an increasing number of specialty clinics and ambulatory centres will further expand the size of cosmetic implants market in the future. The growing influence of social media and the rising awareness among individuals about physical appearance drive the growth of the market in the forecasting period. As per the analysis, the dental implants segment is anticipated to hold remunerative opportunities for the global cosmetic implants market. Various developing countries are making significant developments in their budgets, thereby, offering lucrative opportunities to players in the market. Get Sample PDF Brochu

 As per Future Market Insights, the global  Medical Chairs Market  is poised to expand at a CAGR of 6.0%, exceeding a valuation of US$ 7.7 Bn in 2022 to US$ 13.7 Bn by 2032. Growth in the medical chairs market is increasing in with rising prevalence of physical ailments combined with advancements in control systems. Mobility challenges have long been a source of concern among the elderly, and integrated robotics has prompted a surge in a study into their applications in home-based settings. As a result, rapid technologically advancements in wheelchairs to be commercialized in developing countries will drive the growth. Electric wheelchairs are extensively utilized in airports, hospitals, theatres, tourist attractions, and other public places. The medical chairs market is predicted to expand with growing need of treatment or inspection worldwide. Furthermore, an increase in the geriatric population for rehabilitation purposes is aiding the market growth. Increased prevalence of chronic

 From 2022 to 2032, the Bone Densitometers Market is anticipated to grow at a CAGR of 7.2%. Market size for bone densitometers is anticipated to reach approximately US$ 1.7 billion in 2032, up from US$ 1.12 billion in 2022. FMI gives a thorough study of the market for bone densitometers using the most recent data and statistics from the largest pharmaceutical and healthcare equipment manufacturers worldwide. The research on the existing and projected Market scenario for the Bone Densitometers Market is further aided by FMI's insights into the Market data on more than 5000+ pharmaceuticals for more than 100 countries. To give an unbiased analysis for a wise and financially sound decision, our team of healthcare experts follows the data of both long-standing players and recent arrivals in the medical industry. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14793 Over the past decade, healthcare sector has been expanding remarkably, following the a

 The global  Patient Registry Software Market  is estimated at US$ 4.4 Billion while expanding at a CAGR of 8.8% from 2022 to 2032. The market is valued at US$ 1.9 Billion in 2022. The growth of the market can be attributed to the increasing adoption of EHRs in the healthcare sector. The implementation of various favorable government initiatives is expected to strengthen the market in the forecast period. For instance, in 2016, the U.S introduced Cures Act, which aims to develop medical products and offer innovative technology in the medical sector. Also, the incorporation of AI into EHRs is anticipated to offer various opportunities for expansion. For instance, in October 2019, various scripts along with Northwell Health made an agreement to offer the next-generation electronic health record. The agreement aims to massive revenue generation, thereby, fuelling the market expansion in the coming time. Request Sample Copy of Report @  https://www.futuremarketinsights.com/reports/sample/r

 The Drug Screening Market is likely to thrive at a strong CAGR of 15.1% between 2023 and 2033. The market is anticipated to cross a market share of US$ 32.4 billion by 2033 while it is valued at US$ 7.3 billion in 2023. According to the study report on the drug screening industry, there are more and more people using drugs of all kinds, and there are also more and more rehab facilities. Additionally, the new government regulations that restrict drug usage and drug trafficking are driving up sales of drug screening tools. Authorities are being pushed to limit the distribution of drugs by drug users who encourage violence and drug abuse. The demand for drug screening systems is being fueled by prescription drug abuse and black market sales. Additionally, there is increased interest in developing drug screening products with greater efficiency and effectiveness. The demand for sophisticated drug screening technologies is being fueled by the increased use of recreational drugs among youn

 The Peptide Synthesis Market is anticipated to reach US$ 520.0 million in 2023 and US$ 1.1 billion by 2033. During the forecast period, the market is expected to grow at a CAGR of 8%. As per the Peptide Synthesis Market   survey by Future Market Insights (FMI), the peptide synthesis market is forecasted to register a CAGR of 7% from 2022 to 2032. Growth in this market is majorly influenced by the prevalence of a wide range of applications of peptides in the treatment of various lifestyle disorders, such as cancers, diabetes, and obesity. Owing to their large chemical space, high biological activity, and low toxicity, peptide synthesis in pharmaceutical manufacturing is increasingly being considered as active in drug development and in turn is expected to flourish the peptide synthesis market and rise the adoption of peptide synthesis process. Peptides generate billions of dollars in revenue in oncology, diabetes, and obesity, among other therapeutic areas. The COVID-19 pandemic has p

 During the forecast period, the Blood Collection Devices Market is anticipated to expand at a CAGR of 6.5%. The market valuation is anticipated to reach US$ 7.7 billion in 2023. The sum is anticipated to reach US$ 14.4 billion by 2033. The   Blood Collection Devices Market is poised to attain a CAGR of 6.3% during the forecast period 2022-2032, as per the blood collection devices market analysis by Future Market Insights (FMI). The rising number of accidents and trauma cases, the emergence of liquid biopsy tests, and the demand for blood donations and blood components are some pivotal factors driving the demand for blood collection devices and propelling the market. A major factor shaping the demand for blood collection devices is the rising prevalence of infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV), malaria, syphilis, and brucellosis. A greater emphasis and adherence to health checkups and awareness of disease conditions via bl

 Throughout the projected period, there is expected to be a 7.1% CAGR in the usage of feminine hygiene products. The Feminine Hygiene Products Market is expected to grow from US$ 31.6 billion in 2023 to US$ 62.7 billion by 2033. The following are a few factors driving the market for feminine hygiene products. The value of the global market for feminine hygiene products is predicted to surpass US$ 27.6 billion in 2021, with a CAGR of 7.0% over the forecast period, according to a recent Future Market Insights (FMI) analysis (2021-2031). Females make up over 49% of the world's population, and approximately 65% of them are between the ages of 15 and 65, suggesting a sizable market opportunity for producers of feminine hygiene products. With the aid of the introduction of several awareness programmes and financial initiatives, government agencies are concentrating on the health and cleanliness of women. These sessions cover puberty, menstruation, and the advantages and health advantage

 According to Future Market Insights, the Femtech Market  would generate US$ 1.2 Billion in sales in 2023. The market as a whole is anticipated to reach US$ 5.0 Bn by 2033, growing at a CAGR of 15.2% from 2023 to 2033, driven by rising consumer awareness of women's health. The global Femtech Market is expected to reach a valuation of US$3.8 Bn by the end of 2031, with sales growing at an astounding CAGR of 15% over the assessment period of 2021-2031. The market was valued at US$ 0.94 Bn in 2021. A rising demographic of working women and direct-to-consumer end users are expected to drive the market for the forecast period. Rising cases of infectious diseases among women, growing awareness about general wellness, and the availability of multiple alternatives for educating and destigmatizing women’s health issues are responsible for the upsurge in the femtech market. The burden of infectious diseases like sexually transmitted infections (STIs) is a major driver of the femtech market.

 The Advanced Wound Management Market is projected to secure a valuation of US$ 8.1 billion in 2023 and is anticipated to rise to US$ 11.5 billion by 2033. The market is registering a CAGR of 3.6% during the forecast period. Increasing cases of chronic ulcers, traumatic injuries, obesity, burn wounds, and sedentary lifestyle propel market growth. The growing number of old age population, diabetes, and chronic patients are further increasing the adoption of advanced wound management. There is a growing demand for advanced wound management from patients to heal fast and safely. In the United States, around 34.2 million people were diagnosed with diabetes in 2018. The growing healthcare infrastructure, urbanization, and innovation of modern wound management devices are surging market opportunities. In addition, government support, new market entrance, huge investments, and a growing campaign for patient awareness are booming the market expansion. Moreover, increasing safe treatment by he

 Throughout the projected period, the market for Injectable Drug Delivery Market is anticipated to deepen its foundations at a constant CAGR of 8.9%. The market has a share of US$ 45.3 billion in 2023 and anticipates US$ 106.4 billion in sales by 2033. The market for injectable medication delivery is anticipated to reach US$ 41.5 billion in 2022 and is anticipated to grow at a CAGR of 8.9% from 2022 to 2028, reaching US$ 69.13 billion by the end of 2028. The needle-free injectable drug delivery market dominated the overall injectable drug delivery market in 2017 based on product type. Additionally, due to its simplicity of use, the subtype of prefilled needle-free injectors is anticipated to have a major share of the needle-free type of injectable drug delivery market. Due to the existence of numerous manufacturers of injectable drug delivery devices, the most of which are based in the United States, North America is predicted to continue to dominate the global market for injectable d